Melano I, Azamor T, Caetano C, Meyer N, Onwubueke C, Visperas A, et al. SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated inflammatory diseases. JCI Insight. 2024;9: pubmed publisher

Jiang J, R xf6 per L, Fuchs F, Hanschen M, Failer S, Alageel S, et al. Bone Regenerative Effect of Injectable Hypoxia Preconditioned Serum-Fibrin (HPS-F) in an Ex Vivo Bone Defect Model. Int J Mol Sci. 2024;25: pubmed publisher

Gasparotto M, Di Pierro G, Toffoli B, Grillo A, Bressan M, Fiorentin M, et al. Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDs. J Clin Med. 2024;13: pubmed publisher

Macr xec F, Vigorito I, Castiglione S, Faggiano S, Casaburo M, Fanotti N, et al. High Phosphate-Induced JAK-STAT Signalling Sustains Vascular Smooth Muscle Cell Inflammation and Limits Calcification. Biomolecules. 2023;14: pubmed publisher

Kolliopoulos V, Tiffany A, Polanek M, Harley B. DONOR VARIABILITY IN HUMAN MESENCHYMAL STEM CELL OSTEOGENIC RESPONSE AS A FUNCTION OF PASSAGE CONDITIONS AND DONOR SEX. bioRxiv. 2023;: pubmed publisher

Santos L, Cardoso P, Diniz E, Rahhal J, Sipert C. Different concentrations of fetal bovine serum affect cytokine modulation in Lipopolysaccharide-activated apical papilla cells in vitro. J Appl Oral Sci. 2023;31:e20230020 pubmed publisher

Jeong J, Lee D, Park B, Lee T, Park S. Establishment of a TNFRSF11B knock-out human induced pluripotent stem cell line (KSCBi002-B-2) via CRISPR/Cas9 system. Stem Cell Res. 2023;71:103167 pubmed publisher

Alehagen U, Alexander J, Aaseth J, Larsson A, Svensson E, Opstad T. Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled . Cells. 2023;12: pubmed publisher

Coufal S, Kverka M, Kreisinger J, Thon T, Rob F, Kolar M, et al. Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. J Immunol Res. 2023;2023:1535484 pubmed publisher

Blokland K, Nizamoglu M, Habibie H, Borghuis T, Schuliga M, Melgert B, et al. Substrate stiffness engineered to replicate disease conditions influence senescence and fibrotic responses in primary lung fibroblasts. Front Pharmacol. 2022;13:989169 pubmed publisher

Nicholson T, Davis L, Davis E, Newton Ede M, Scott A, Jones S. e-Cigarette Vapour Condensate Reduces Viability and Impairs Function of Human Osteoblasts, in Part, via a Nicotine Dependent Mechanism. Toxics. 2022;10: pubmed publisher

Galla R, Ruga S, Aprile S, Ferrari S, Brovero A, Grosa G, et al. New Hyaluronic Acid from Plant Origin to Improve Joint Protection-An In Vitro Study. Int J Mol Sci. 2022;23: pubmed publisher

Jiang J, R xf6 per L, Alageel S, Dornseifer U, Schilling A, Hadjipanayi E, et al. Hypoxia Preconditioned Serum (HPS) Promotes Osteoblast Proliferation, Migration and Matrix Deposition. Biomedicines. 2022;10: pubmed publisher

Kim H, Park M, Joo A, Kang S, Eum S, Chang Y, et al. Plasma osteoprotegerin level is associated with hemorrhagic transformation in stroke patients who underwent endovascular thrombectomy. Clin Neurol Neurosurg. 2022;219:107305 pubmed publisher

Park M, Park J, Joo A, Chang Y, Song T. The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study. Peerj. 2022;10:e13327 pubmed publisher

Passaponti S, Ermini L, Acconci G, Severi F, Romagnoli R, Cutrupi S, et al. Rank-Rankl-Opg Axis in Multiple Sclerosis: The Contribution of Placenta. Cells. 2022;11: pubmed publisher

Hinkelmann S, Springwald A, Schulze S, Hempel U, Mitrach F, Wölk C, et al. Mineralizing Gelatin Microparticles as Cell Carrier and Drug Delivery System for siRNA for Bone Tissue Engineering. Pharmaceutics. 2022;14: pubmed publisher

Kennedy J, Tsimbouri P, Campsie P, Sood S, Childs P, Reid S, et al. Nanovibrational stimulation inhibits osteoclastogenesis and enhances osteogenesis in co-cultures. Sci Rep. 2021;11:22741 pubmed publisher

Park M, Chang Y, Kim K, Park J, Song T. Plasma osteoprotegerin levels are associated with the presence and burden of cerebral small vessel disease in patients with acute ischemic stroke. Clin Neurol Neurosurg. 2021;210:107010 pubmed publisher

Noda K, Dufner B, Ito H, Yoshida K, Balboni G, Straub R. Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis. Sci Rep. 2021;11:18399 pubmed publisher

Blokland K, Habibie H, Borghuis T, Teitsma G, Schuliga M, Melgert B, et al. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM. Cells. 2021;10: pubmed publisher

Barber B, Grigg M, Piera K, Chen Y, William T, Weinberg J, et al. Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria. Sci Rep. 2021;11:9741 pubmed publisher

Shetty B, Divakar D, Al Kheraif A, Alharbi A, Almutairi M, Alanazi M. Role of PDT as an adjunct to SRP on whole salivary RANKL and OPG ratio in type-2 diabetic and normoglycemic individuals with chronic periodontitis. Photodiagnosis Photodyn Ther. 2021;34:102220 pubmed publisher

Marques G, Hayashi S, Bjällmark A, Larsson M, Riella M, Olandoski M, et al. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5. Sci Rep. 2021;11:2473 pubmed publisher

Pihlstrøm H, Ueland T, Michelsen A, Aukrust P, Gatti F, Hammarstrom C, et al. Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients. PLoS ONE. 2020;15:e0243759 pubmed publisher

Bernardi S, Toffoli B, Tonon F, Francica M, Campagnolo E, Ferretti T, et al. Sex Differences in Proatherogenic Cytokine Levels. Int J Mol Sci. 2020;21: pubmed publisher

Adhyatmika A, Beljaars L, Putri K, Habibie H, Boorsma C, Reker Smit C, et al. Osteoprotegerin is More than a Possible Serum Marker in Liver Fibrosis: A Study into its Function in Human and Murine Liver. Pharmaceutics. 2020;12: pubmed publisher

Yeh I, Chen S, Yen M, Wu Y, Hung C, Kuo P. 6-Shogaol Suppresses 2-Amino-1-Methyl-6-Phenylimidazo [4,5-b] Pyridine (PhIP)-Induced Human 786-O Renal Cell Carcinoma Osteoclastogenic Activity and Metastatic Potential. Nutrients. 2019;11: pubmed publisher

Coufal S, Galanova N, Bajer L, Gajdarova Z, Schierova D, Jiraskova Zakostelska Z, et al. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells. 2019;8: pubmed publisher

Segaliny A, Cheng J, Farhoodi H, Toledano M, Yu C, Tierra B, et al. Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells. EBioMedicine. 2019;45:39-57 pubmed publisher

Kang J, Choi Y, Seo B, Jo U, Park S, Kim Y, et al. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment. Sci Rep. 2019;9:8726 pubmed publisher

Benjakul S, Leethanakul C, Jitpukdeebodintra S. Low magnitude high frequency vibration induces RANKL via cyclooxygenase pathway in human periodontal ligament cells in vitro. J Oral Biol Craniofac Res. 2019;9:251-255 pubmed publisher

Ren X, Zhou Q, Foulad D, Tiffany A, Dewey M, Bischoff D, et al. Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds. Sci Adv. 2019;5:eaaw4991 pubmed publisher

Cao Y, Cui C, Zhao H, Pan X, Li W, Wang K, et al. Plasma Osteoprotegerin Correlates with Stroke Severity and the Occurrence of Microembolic Signals in Patients with Acute Ischemic Stroke. Dis Markers. 2019;2019:3090364 pubmed publisher

Chatmahamongkol C, Pravitharangul A, Suttapreyasri S, Leethanakul C. The effect of compressive force combined with mechanical vibration on human alveolar bone osteoblasts. J Oral Biol Craniofac Res. 2019;9:81-85 pubmed publisher

Sui B, Chen J, Zhang X, He T, Zhao P, Zheng C, et al. Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery. Exp Mol Med. 2018;50:166 pubmed publisher

McNeill E, Reese R, Tondon A, Clough B, Pan S, Froese J, et al. Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibition. Cell Death Dis. 2018;9:1161 pubmed publisher

Sassi F, Buondonno I, Luppi C, Spertino E, Stratta E, Di Stefano M, et al. Type 2 diabetes affects bone cells precursors and bone turnover. BMC Endocr Disord. 2018;18:55 pubmed publisher

Boyan B, Olivares Navarrete R, Berger M, Hyzy S, Schwartz Z. Role of Wnt11 during Osteogenic Differentiation of Human Mesenchymal Stem Cells on Microstructured Titanium Surfaces. Sci Rep. 2018;8:8588 pubmed publisher

Vorkapic E, Kunath A, Wågsäter D. Effects of osteoprotegerin/TNFRSF11B in two models of abdominal aortic aneurysms. Mol Med Rep. 2018;18:41-48 pubmed publisher

Ochanji A, Matu N, Mulli T. Association of salivary RANKL and osteoprotegerin levels with periodontal health. Clin Exp Dent Res. 2017;3:45-50 pubmed publisher

Davenport C, Harper E, Rochfort K, Forde H, Smith D, Cummins P. RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain. J Vasc Res. 2018;55:111-123 pubmed publisher

Mizoguchi F, Slowikowski K, Wei K, Marshall J, Rao D, Chang S, et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018;9:789 pubmed publisher

Clough B, Zeitouni S, Krause U, Chaput C, Cross L, Gaharwar A, et al. Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen-Synthease-Kinase-3-Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo. Stem Cells Transl Med. 2018;7:342-353 pubmed publisher

Ueland T, Ã…kerblom A, Ghukasyan T, Michelsen A, Aukrust P, Becker R, et al. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Heart Assoc. 2018;7: pubmed publisher

Harper E, Rochfort K, Forde H, Davenport C, Smith D, Cummins P. TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models. PLoS ONE. 2017;12:e0188192 pubmed publisher

Bernardi S, Toffoli B, Bossi F, Candido R, Stenner E, Carretta R, et al. Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients. BMC Nephrol. 2017;18:219 pubmed publisher

Abu El Asrar A, Struyf S, Mohammad G, Gouwy M, Rytinx P, Siddiquei M, et al. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017;58:3189-3201 pubmed publisher

Rogers M, Maldonado N, Hutcheson J, Goettsch C, Goto S, Yamada I, et al. Dynamin-Related Protein 1 Inhibition Attenuates Cardiovascular Calcification in the Presence of Oxidative Stress. Circ Res. 2017;121:220-233 pubmed publisher

Morisawa T, Nakagomi A, Kohashi K, Kusama Y, Shimizu W. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease. J Atheroscler Thromb. 2017;24:1058-1068 pubmed publisher

Chung S, Geerts D, Roseman K, Renaud A, Connelly L. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. Mol Cancer. 2017;16:27 pubmed publisher

Shin S, Kim K, Choi N, Kim I, Park B, Kim Y, et al. Effect of low-level laser therapy on bisphosphonate-treated osteoblasts. Maxillofac Plast Reconstr Surg. 2016;38:48 pubmed publisher

Yao S, Zhang Y, Tang L, Roh J, Laurent C, Hong C, et al. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017;161:501-513 pubmed publisher

Tibana R, de Almeida L, Frade de Sousa N, Nascimento D, Neto I, de Almeida J, et al. Two Consecutive Days of Crossfit Training Affects Pro and Anti-inflammatory Cytokines and Osteoprotegerin without Impairments in Muscle Power. Front Physiol. 2016;7:260 pubmed publisher

Wang X, Sun X, Zhang C, Yang X, Yan W, Ge L, et al. RUNX2 Mutation Impairs 1?,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells. Sci Rep. 2016;6:24225 pubmed publisher

O Regan N, Moxon C, Gegenbauer K, O Sullivan J, Chion A, Smith O, et al. Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria. Thromb Haemost. 2016;115:773-80 pubmed publisher

Pan X, Pang M, Ma A, Wang K, Zhang Z, Zhong Q, et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. PLoS ONE. 2015;10:e0136414 pubmed publisher

Lewis J, Lim W, Ueland T, Wong G, Zhu K, Lim E, et al. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. PLoS ONE. 2015;10:e0134266 pubmed publisher

Chung C, Solus J, Oeser A, Li C, Raggi P, Smith J, et al. A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. Int J Mol Sci. 2015;16:3885-94 pubmed publisher

Grisendi G, Spano C, D Souza N, Rasini V, Veronesi E, Prapa M, et al. Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas. Stem Cells. 2015;33:859-69 pubmed publisher

Chen W, Foo S, Taylor A, Lulla A, Merits A, Hueston L, et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol. 2015;89:581-93 pubmed publisher

Davaine J, Quillard T, Brion R, Lapérine O, Guyomarch B, Merlini T, et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. PLoS ONE. 2014;9:e107642 pubmed publisher

Hansen D, Rasmussen K, Rasmussen L, Bruunsgaard H, Brandi L. The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study. BMC Nephrol. 2014;15:130 pubmed publisher

Clancy P, Koblar S, Golledge J. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation. Atherosclerosis. 2014;236:108-15 pubmed publisher

Broch K, Askevold E, Gjertsen E, Ueland T, Yndestad A, Godang K, et al. The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PLoS ONE. 2014;9:e89732 pubmed publisher

Wulf Johansson H, Lock Johansson S, Schlosser A, Trommelholt Holm A, Rasmussen L, Mickley H, et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. PLoS ONE. 2013;8:e82243 pubmed publisher

Sato W, Tomita A, Ichikawa D, Lin Y, Kishida H, Miyake S, et al. CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis. J Immunol. 2012;189:5057-65 pubmed publisher

Chen Y, Wu Y, Yang W, Wang S, Lee C, Chou N, et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. PLoS ONE. 2012;7:e44242 pubmed publisher

Rattazzi M, Faggin E, Galliazzo S, Puato M, Caberlotto L, Scannapieco G, et al. Osteoprotegerin levels are increased in patients with venous thromboembolic disease. J Thromb Haemost. 2012;10:1183-5 pubmed publisher

Poulsen M, Nybo M, Dahl J, Hosbond S, Poulsen T, Johansen A, et al. Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. Cardiovasc Diabetol. 2011;10:76 pubmed publisher

Vik A, Mathiesen E, Brox J, Wilsgaard T, Njølstad I, Jørgensen L, et al. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. J Thromb Haemost. 2011;9:638-44 pubmed publisher

Olivares Navarrete R, Hyzy S, Wieland M, Boyan B, Schwartz Z. The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces. Biomaterials. 2010;31:2015-24 pubmed publisher

Golledge J, Biros E, Clancy P, Cooper M, Palmer L, Norman P. A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. Am J Hypertens. 2009;22:1167-70 pubmed publisher

Eagan T, Ueland T, Wagner P, Hardie J, Mollnes T, Damas J, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35:540-8 pubmed publisher

Clark A, Yip P, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci. 2009;29:6945-54 pubmed publisher

Nybo M, Johnsen S, Dethlefsen C, Overvad K, Tjønneland A, Jørgensen J, et al. Lack of observed association between high plasma osteoprotegerin concentrations and ischemic stroke risk in a healthy population. Clin Chem. 2008;54:1969-74 pubmed publisher

Secchiero P, Lamberti G, Corallini F, Melloni E, Guarnotta C, Sebastiani A, et al. Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye. J Cell Physiol. 2009;218:199-204 pubmed publisher

Jorsal A, Tarnow L, Flyvbjerg A, Parving H, Rossing P, Rasmussen L. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetologia. 2008;51:2100-7 pubmed publisher

Granchi D, Baglìo S, Amato I, Giunti A, Baldini N. Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells. Int J Cancer. 2008;123:1526-35 pubmed publisher

Nybo M, Rasmussen L. Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells. Atherosclerosis. 2008;201:33-5 pubmed publisher

Raje N, Woo S, Hande K, Yap J, Richardson P, Vallet S, et al. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008;14:2387-95 pubmed publisher

Locklin R, Federici E, Espina B, Hulley P, Russell R, Edwards C. Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. Mol Cancer Ther. 2007;6:3219-28 pubmed

Vestergaard E, Andersen N, Hansen T, Rasmussen L, Moller N, Sorensen K, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol. 2007;293:H3020-6 pubmed

Lamoureux F, Richard P, Wittrant Y, Battaglia S, Pilet P, Trichet V, et al. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res. 2007;67:7308-18 pubmed

Kiechl S, Schett G, Schwaiger J, Seppi K, Eder P, Egger G, et al. Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease. Circulation. 2007;116:385-91 pubmed

Vik A, Brodin E, Sveinbjørnsson B, Hansen J. Heparin induces mobilization of osteoprotegerin into the circulation. Thromb Haemost. 2007;98:148-54 pubmed

Naot D, Bava U, Matthews B, Callon K, Gamble G, Black M, et al. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res. 2007;22:298-309 pubmed

Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux N, et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006;169:987-98 pubmed

Bersinger N, von Roten S, Wunder D, Raio L, Dreher E, Mueller M. PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. Am J Obstet Gynecol. 2006;195:103-8 pubmed

de Vries T, Schoenmaker T, Wattanaroonwong N, van den Hoonaard M, Nieuwenhuijse A, Beertsen W, et al. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J Cell Biochem. 2006;98:370-82 pubmed

Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res. 2004;83:166-9 pubmed

Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol. 2003;163:2021-31 pubmed